SCL Science Inc. (KOSDAQ:246960)
2,255.00
+10.00 (0.45%)
At close: Sep 3, 2026
SCL Science Revenue
SCL Science had revenue of 7.59B KRW in the quarter ending June 30, 2026, with 68.91% growth. This brings the company's revenue in the last twelve months to 30.50B, up 194.27% year-over-year. In the year 2025, SCL Science had annual revenue of 22.01B with 364.64% growth.
Revenue (ttm)
30.50B
Revenue Growth
+194.27%
P/S Ratio
2.49
Revenue / Employee
n/a
Employees
n/a
Market Cap
76.02B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.01B | 17.27B | 364.64% |
| Dec 31, 2024 | 4.74B | 3.42B | 258.30% |
| Dec 31, 2023 | 1.32B | 952.33M | 257.54% |
| Dec 31, 2022 | 369.78M | -137.51M | -27.11% |
| Dec 31, 2021 | 507.29M | -88.90M | -14.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| KM Corporation | 144.10B |
| JW Shinyak | 81.04B |
| Sewoon Medical | 66.53B |
| CG MedTech | 51.20B |
| OSTEONIC | 50.97B |
| DuChemBIO | 41.51B |
| Wonbiogen | 37.80B |
| Plasmapp | 12.02B |